Technical articles
20/06/2023
Biocompatibility assessment of MD (ISO/TR 10993-55:2023)
Assessing the biocompatibility of medical devices is of major importance as it ensures the biological safety of products with rega
8/06/2023
Grenoble is packing up and changing premises!
Welcome to the new premises of our Grenoble agency!!
29/05/2023
Efor becomes a patron of Centre Leon BERARD and commits to the fight against cancer
We are proud to announce that we are supporting the Leon BERARD cancer center.
11/02/2023
Efor US. is born
Before closing 2022 marked by growth, resilience and starting a new year rich in projects ...
Join our team
Consult our offers
4/10/2022
EU GMP Annex 1 update: what has changed, and what are the impacts?
EU GMP Annex 1 on good manufacturing practice defines rules for the manufacture of sterile medicinal products. Based on a 2008 ver
14/09/2022
Launching Virtual Reality Training Programs
Tree, the training center of the Efor Group, reinforces its expertise and innovation capacity through immersive virtual reality tr
17/11/2021
The headquarters of Efor Group is moving.
The Lyon-based teams of Efor and CVO-EUROPE are relocating to the brand new premises at Racing Park in Champagne au mont d’o
21/09/2021
Evaluating the biocompatibility of medical devices
Background information Evaluating the biocompatibility of medical devices (MDs) is of major importance as it ensures the safe
5/09/2021
Soladis joins the Efor Group, bringing 20 years of expertise in statistics and data management
At the end of 2020, our group joined forces with CVO-EUROPE , a company with over 25 years' experience working with major pharmac
27/07/2021
Data Integrity – The adventures continues
Why data integrity?Data are central to all our interactions, communications and strategic decision-making. In the pharmaceutical a
